Quay lại
Giá Duality Biotherapeutics, Inc. (09606.HK)
Biểu đồ giá cổ phiếu 09606.HK
DUALITYBIO-B (09606.HK)
Duality Biotherapeutics, Inc.
HK$359
-1.04%
$-3.8
Thị trường đóng cửa: Jan 16, 16:00:00 HKT
Thống kê chính
Giá đóng cửa trước
$362.8
Giá mở cửa
$362.8
Phạm vi ngày
$351.8 - $364.8
Phạm vi 52 tuần
$165.5 - $563.5
Khối lượng
689.5K
Khối lượng trung bình
1.2M
EPS (TTM)
-35.81
Tỷ suất cổ tức
--
Vốn hóa thị trường
$31.6B
DUALITYBIO-B là gì?
Duality Biotherapeutics, Inc. operates as a clinical stage company. The company is headquartered in Shanghai, Shanghai and currently employs 191 full-time employees. The company went IPO on 2025-04-15. The firm is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The firm's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The firm's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The firm principally conducts its businesses in domestic and overseas markets.
Đặc điểm
Chiến lược giao dịch
Tài nguyên
© 2025 Finture Development Limited. All rights reserved
